SERGIO CHANG FIGUEROA: Open Payments
NPI 1447498522 · MADISONVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$112,817 in 290 payments from 22 companies in 2025. Trend: 2023 $144,577 · 2024 $138,630 · 2025 $112,817
Speaker / faculty: $86,501Travel & lodging: $9,873Honoraria: $8,790Food & beverage: $5,910Speaker / faculty: $1,688Education: $56
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 45 | $31,374 |
| Lilly USA, LLC | 48 | $26,256 |
| Bayer Healthcare Pharmaceuticals Inc. | 37 | $24,516 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 26 | $14,478 |
| Corcept Therapeutics | 25 | $12,276 |
| Abbott Laboratories | 6 | $1,751 |
| Medtronic, Inc. | 23 | $818 |
| Mannkind Corporation | 21 | $389 |
| Insulet Corporation | 13 | $188 |
| Amgen Inc. | 10 | $142 |
Products named: Ozempic, Kerendia, JARDIANCE, Korlym, MOUNJARO, FREESTYLE LIBRE 3, MINIMED 780G, AFREZZA.
Industry payments across KY — which companies pay providers there.
